SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Perney, P
Right arrow Articles by Blanc, F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perney, P
Right arrow Articles by Blanc, F
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Antiphospholipid antibodies in alcoholic liver disease are influenced by histological damage but not by alcohol consumption

P Perney

Service de Medecine Inteme E, H6pital Saint Eloi, 2 avenue Bertin-Sans, 34295 Montpellier Cedex 5, France. Tel: (+33) 4 67 33 73 30; Fax: (+33) 4 67 33 78 69.

C Biron-Andreani

Laboratoire d'Hematologie, Hopital Saint Eloi, Montpellier, France

Z Joomaye

P Fabbro-Peray

Service de MWdecine Interne E, Montpellier, France

F Quenet

CRLC Val d'Aurelle, Montpellier, France

J F Schved

Laboratoire d'Hematologie, Hopital Saint Eloi, Montpellier, France

F Blanc

Service de MWdecine Interne E, Montpellier, France

Antiphospholipid antibodies (aPL) have been detected in various liver diseases, particularly cirrhosis. The role of alcoholic consumption per se has been suggested. The aim of our study was to assess the prevalence of aPL in patients with alcoholic liver disease at various states and to correlate the presence of aPL with both liver injury and alcoholic consumption.

Three groups were prospectively included. Group A: 74 controls (age-and sex-matched); group B: 46 patients with alcoholic steatosis; group C: 28 patients with alcoholic cirrhosis. For each patient, lupus anticoagulant, anticardiolipin antibodies and anti-j32-glycoprotein I antibodies were tested.

The prevalence of aPL (presence of at least one positive test) was 5% in group A, 20% in group B and 50% in group C (P < 0.04). No correlation appeared between aPL and Child Pugh score in group C. No correlation was found between the presence of aPL and alcohol intake in patients with either steatosis or cirrhosis. Our study confirms that aPL positivity is more frequently encountered in patients with alcoholic liver disease than in controls. Their prevalence increases with the degree of histological damage but not with the level of alcoholic intake.

Key Words: antiphospholipid antibodies • anticardiolipin antibodies • anti-fl2-glycoprotein I antibodies • alcoholic liver disease • alcohol consumption

Lupus, Vol. 9, No. 6, 451-455 (2000)
DOI: 10.1191/096120300678828659


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
I. Uthman and M. Khamashta
The abdominal manifestations of the antiphospholipid syndrome
Rheumatology, November 1, 2007; 46(11): 1641 - 1647.
[Abstract] [Full Text] [PDF]



Advertisement